Annual Drug Patent Expirations for EMPAVELI
Empaveli is a drug marketed by Apellis Pharms and is included in one NDA. There are seven patents protecting this drug.
This drug has one hundred and thirteen patent family members in twenty-three countries.
The generic ingredient in EMPAVELI is pegcetacoplan. Additional details are available on the pegcetacoplan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
